Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea

BACKGROUND: Nowadays there is a debate about the indication of the oral whole-cell/recombinant B-subunit cholera vaccine (WC/rBS) in traveller's diarrhoea. However, a cost-benefit analysis based on real data has not been published. METHODS: A cost-effectiveness and cost-benefit study of the ora...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Gigosos, Rosa, Garcia-Fortea, Pedro, Calvo, Maria J, Reina, Emilia, Diez-Diaz, Rosa, Plaza, Elena
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686703/
https://www.ncbi.nlm.nih.gov/pubmed/19445712
http://dx.doi.org/10.1186/1471-2334-9-65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686703/
https://www.ncbi.nlm.nih.gov/pubmed/19445712
http://dx.doi.org/10.1186/1471-2334-9-65

Ejemplares similares